Related references
Note: Only part of the references are listed.Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
Jill R. Dietz et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Telemedicine and the COVID-19 Pandemic, Lessons for the Future
Rashid Bashshur et al.
TELEMEDICINE AND E-HEALTH (2020)
The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China
Hien Lau et al.
JOURNAL OF TRAVEL MEDICINE (2020)
The Mental Health Consequences of COVID-19 and Physical Distancing The Need for Prevention and Early Intervention
Sandro Galea et al.
JAMA INTERNAL MEDICINE (2020)
COVID-19 and Italy: what next?
Andrea Remuzzi et al.
LANCET (2020)
COVID-19: global consequences for oncology
The Lancet Oncology
LANCET ONCOLOGY (2020)
Caring for patients with cancer in the COVID-19 era
Joris van de Haar et al.
NATURE MEDICINE (2020)
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic
Giuseppe Curigliano et al.
BREAST (2020)
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic
Mitch Dowsett et al.
NPJ BREAST CANCER (2020)
Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study
Joel R. Koo et al.
LANCET INFECTIOUS DISEASES (2020)
The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study
Rachel L. O'Connell et al.
BRITISH JOURNAL OF CANCER (2019)
Cancer Outcomes in DCIS Patients Without Locoregional Treatment
Marc D. Ryser et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)
E. Shelley Hwang et al.
BMJ OPEN (2019)
Characteristics and Outcomes of Surgical Patients With Solid Cancers Admitted to the Intensive Care Unit
Kathryn Puxty et al.
JAMA SURGERY (2018)
Time to Surgery and Breast Cancer Survival in the United States
Richard J. Bleicher et al.
JAMA ONCOLOGY (2016)
Reoperation for Complications after Lumpectomy and Mastectomy for Breast Cancer from the 2012 National Surgical Quality Improvement Program (ACS-NSQIP)
Zahraa Al-Hilli et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Addressing overtreatment of screen detected DCIS; the LORIS trial
Adele Francis et al.
EUROPEAN JOURNAL OF CANCER (2015)
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study
Lotte E. Elshof et al.
EUROPEAN JOURNAL OF CANCER (2015)
One-Year Neoadjuvant Endocrine Therapy in Breast Cancer
Orsolya Rusz et al.
PATHOLOGY & ONCOLOGY RESEARCH (2015)
Efficacy of six month neoadjuvant endocrine therapy in postmenopausal, hormone receptor-positive breast cancer patients - A phase II trial
Duveken B. Y. Fontein et al.
EUROPEAN JOURNAL OF CANCER (2014)
Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool
Y. H. Chia et al.
BRITISH JOURNAL OF CANCER (2010)
Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer:: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy
Ute E. Krainick-Strobel et al.
BMC CANCER (2008)
Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
D Hind et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
Share Paper
